谷歌浏览器插件
订阅小程序
在清言上使用

Anti-slit Diaphragm Antibodies on Kidney Biopsy Identify Pediatric Patients with Steroid-Resistant Nephrotic Syndrome Responsive to Second-Line Immunosuppressants.

Valentina Raglianti,Maria Lucia Angelotti, Luigi Cirillo, Fiammetta Ravaglia, Samuela Landini, Viviana Palazzo,Maria Elena Melica,Giulia Antonelli,Carolina Conte, Elisa Buti, Carmela Errichiello, Letizia De Chiara, Anna J Peired, Laura Lasagni,Anna Maria Buccoliero, Marco Allinovi, Anna Manonelles Montero, Josep Maria Cruzado,Maurizio Bruschi,Gian Marco Ghiggeri,Andrea Angeletti, Hans-Joachim Anders, Elena Lazzeri, Benedetta Mazzinghi,Francesca Becherucci,Paola Romagnani

Kidney international(2024)

引用 0|浏览0
暂无评分
摘要
Podocytopathies represent a group of glomerular disorders associated with minimal changes (MC) or focal segmental glomerulosclerosis (FSGS) lesion patterns at biopsy and heterogeneous responses to steroids. Anti-nephrin antibodies were previously found in such patients, suggesting an autoimmune form of podocytopathy. High resolution confocal microscopy on kidney biopsies of a cohort of 128 pediatric patients revealed localization of IgG along the slit diaphragm in 30% of patients with MC and 25% of those with FSGS, but not in other lesion patterns. Anti-nephrin IgG ELISA assay in the serum and stimulated emission depletion microscopy of kidney biopsies showed IgG-nephrin co-localization only in 77.8% of cases. Similar observations were obtained in a cohort of 48 adult patients with MC or FSGS at kidney biopsy, where IgG-nephrin colocalization was only 44.4%, suggesting the existence of autoantibodies binding to other slit proteins. Patients with anti-slit antibodies showed nephrotic syndrome at onset in 94.4% of cases. Patients with primary steroid-resistance had anti-slit antibodies in 27%, while those with secondary steroid-resistance in 87.5% of cases, irrespective of the histopathological lesion pattern. Steroid-resistant patients with anti-slit antibodies responded to second-line immunosuppressants in 92.3% vs. only 20% of patients that were anti-slit negative. No patient with anti-slit antibodies developed kidney failure vs. 51.7% of those negative for antibodies (66.7% with a genetic cause and 41.2% with a non-genetic cause). Thus, the detection of anti-slit antibodies can identify patients with an autoimmune podocytopathy responsive to treatment with second-line immunosuppressants, irrespective of the histopathological lesion pattern at biopsy.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要